Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
1. 系统已在2025-11-20 12:15:33对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1158/1078-0432.CCR-21-4097
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Mingzhi Zhang; Dan Chen; Xiaorui Fu; Huimin Meng; Feifei Nan; Zhenchang Sun; Hui Yu; Lei Zhang; Ling Li; Xin Li; Xinhua Wang; Min Wang; Fengtao You; Zhaoming Li; Yu Chang; Zhiyuan Zhou; Jiaqin Yan; Jiwei Li; Xiaolong Wu; Yu Wang; Yinyan Wang; Shufen Xiang; YuSheng Chen; Guifang Pan; Hanying Xu; Bozhen Zhang; Lin Yang
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-21-4097/3114972/ccr-21-4097.pdf

